Mo'tassem Al-arydah

Learn More
Recently, a vaccine for human papillomavirus was introduced, but made available only for girls and adult women aged 13–26. Since rates of sexual activity vary by age and gender, vaccinating only an age-limited subset of one cohort may be insufficient to control the disease across all age groups and genders. We develop an age-dependent two-sex mathematical(More)
  • 1